Bo Cui

277, Yanta West Road
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

CXCL8 Enhances Malignancy of GBM via TNFα-NFκB Mediated Suppression of Ferroptosis.

CXCL8 Enhances Malignancy of GBM via TNFα-NFκB Mediated Suppression of Ferroptosis.

Journal: Applied biochemistry and biotechnology

Published: May 21, 2026

Study on the combined influence mechanism of temperature, density and moisture content on the resistivity of loess.

Study on the combined influence mechanism of temperature, density and moisture content on the resistivity of loess.

Journal: Scientific reports

Published: July 06, 2025

WTAP Promotes Malignant Progression and Immune Escape of Glioblastoma by Regulating N6-methyladenosine Modification of CENPF.

WTAP Promotes Malignant Progression and Immune Escape of Glioblastoma by Regulating N6-methyladenosine Modification of CENPF.

Journal: Journal of biochemical and molecular toxicology

Published: January 04, 2025

Study on the characteristics particles of coarse grain material in high bench dump.

Study on the characteristics particles of coarse grain material in high bench dump.

Journal: Scientific reports

Published: July 01, 2024

LncRNA MYMLR promotes pituitary adenoma development by upregulating carbonyl reductase 1 via sponging miR-197-3p.

LncRNA MYMLR promotes pituitary adenoma development by upregulating carbonyl reductase 1 via sponging miR-197-3p.

Journal: Anti-cancer drugs

Published: October 07, 2022

Erratum: Dihydroartemisinin suppresses proliferation, migration, the Wnt/β-catenin pathway and EMT via TNKS in gastric cancer.

Erratum: Dihydroartemisinin suppresses proliferation, migration, the Wnt/β-catenin pathway and EMT via TNKS in gastric cancer.

Journal: Oncology letters

Published: December 30, 2021

MicroRNA-30e-3p inhibits glioma development and promotes drug sensitivity to temozolomide treatment via targeting canopy FGF signaling regulator 2.

MicroRNA-30e-3p inhibits glioma development and promotes drug sensitivity to temozolomide treatment via targeting canopy FGF signaling regulator 2.

Journal: Cell cycle (Georgetown, Tex.)

Published: October 18, 2021

Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.

Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.

Journal: Cell cycle (Georgetown, Tex.)

Published: May 24, 2021

Dihydroartemisinin suppresses proliferation, migration, the Wnt/β-catenin pathway and EMT via TNKS in gastric cancer.

Dihydroartemisinin suppresses proliferation, migration, the Wnt/β-catenin pathway and EMT via TNKS in gastric cancer.

Journal: Oncology letters

Published: December 19, 2020

miR-23b-5p promotes the chemosensitivity of temozolomide via negatively regulating TLR4 in glioma.

miR-23b-5p promotes the chemosensitivity of temozolomide via negatively regulating TLR4 in glioma.

Journal: Acta biochimica et biophysica Sinica

Published: August 31, 2020

miR-4530 inhibits the malignant biological behaviors of human glioma cells by directly targeting RTEL1.

miR-4530 inhibits the malignant biological behaviors of human glioma cells by directly targeting RTEL1.

Journal: Acta biochimica et biophysica Sinica

Published: May 22, 2020

Resveratrol ameliorates diabetic nephropathy in rats through negative regulation of the p38 MAPK/TGF-β1 pathway.

Resveratrol ameliorates diabetic nephropathy in rats through negative regulation of the p38 MAPK/TGF-β1 pathway.

Journal: Experimental and therapeutic medicine

Published: January 05, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026